Morgan Stanley Cellebrite Di Ltd. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Morgan Stanley holds 5,375,390 shares of CLBT stock, worth $140 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,375,390
Previous 6,991,071
23.11%
Holding current value
$140 Million
Previous $83.5 Million
8.35%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding CLBT
# of Institutions
183Shares Held
88.3MCall Options Held
741KPut Options Held
205K-
True Wind Capital Management, L.P.13.9MShares$360 Million87.15% of portfolio
-
Acadian Asset Management LLC Boston, MA4.39MShares$114 Million0.23% of portfolio
-
Nine Ten Capital Management LLC Evanston, IL4.33MShares$112 Million22.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L33.5MShares$90.9 Million0.69% of portfolio
-
Crosslink Capital Inc Menlo Park, CA3.49MShares$90.7 Million7.89% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $4.93B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...